Stockscreener 앱 받기
23.65
1.50%
-0.36
시간 외 거래:
23.59
-0.06
-0.25%
전일 마감가:
$24.01
열려 있는:
$24.16
하루 거래량:
8.28M
Relative Volume:
1.57
시가총액:
$11.81B
수익:
$4.72B
순이익/손실:
$-232.00M
주가수익비율:
-50.72
EPS:
-0.4663
순현금흐름:
$284.00M
1주 성능:
+5.06%
1개월 성능:
+0.21%
6개월 성능:
+10.05%
1년 성능:
+92.59%
1일 변동 폭
$22.91
$24.58
1주일 범위
$22.41
$26.29
52주 변동 폭
$11.92
$27.72
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
Compare ELAN vs TAK, TEVA, HLN, ZTS, UTHR
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
23.65 | 11.81B | 4.72B | -232.00M | 284.00M | -0.4663 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.00B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.60B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 40.43B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 34.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 23.98B | 3.18B | 1.33B | 1.04B | 27.90 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-15 | 개시 | Citigroup | Buy |
| 2026-01-22 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Q3 2025 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Elanco Animal Health Inc Investor Day Transcript - GuruFocus
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Elanco Animal Health Price Target Raised to $31.00/Share From $30.00 by Citigroup - Moomoo
ELAN Maintained by Citigroup -- Price Target Raised to $31.00 - GuruFocus
ELAN Maintained by JP Morgan -- Price Target Raised to $30 - GuruFocus
Elanco Earnings Call Highlights Innovation-Led Growth - The Globe and Mail
Elanco Animal Health Is Maintained at Overweight by JP Morgan - Moomoo
Elanco Animal Health Boosts Full Year Forecast - marketscreener.com
Elanco Animal Health (ELAN) Is Up 20.1% After Raising 2026 Guidance On Innovation-Led Growth - Yahoo Finance
Q1 2026 Elanco Animal Health Inc Earnings Call Transcript - GuruFocus
Elanco Animal Health Incorporated (NYSE:ELAN) Q1 2026 Earnings Call Transcript - Insider Monkey
Jefferies raises Elanco Animal Health stock price target to $30 By Investing.com - Investing.com Canada
Stifel reiterates Buy on Elanco Animal Health stock, $32 target By Investing.com - Investing.com Canada
ELAN Q1 Deep Dive: Innovation Products and Margin Expansion Steer Strong Start - The Globe and Mail
MSN Money - MSN
Elanco jumps after Q1 beat and higher 2026 outlook - Quiver Quantitative
Elanco Animal Health CEO reveals efforts to stop screwworm outbreak - Fox Business
BofA raises Elanco Animal Health stock price target on strong Q1 - Investing.com Canada
Elanco Animal Health Moves Higher On Earnings Strength And Product Momentum - Benzinga
Elanco Animal Health 2026 Q1 10-Q: Financial Results, Risk Factors, and Forward-Looking Statements - Minichart
Elanco Animal Health Q1 2026 Earnings Call Transcript - MarketBeat
Elanco’s stock climbs after company posts strong 1st quarter results - Indianapolis Business Journal
Elanco Is Finally Realizing Its Transformation From Caterpillar to Butterfly - Morningstar
Elanco Animal Health Incorporated Q1 2026 Earnings Call Summary - Yahoo Finance
Elanco (ELAN) Q1 2026 Earnings Transcript - The Globe and Mail
Elanco Animal Health Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Elanco Animal Health Incorporated (ELAN) beats Q1 earnings and revenue estimates - MSN
Elanco Q1 2026 slides: innovation drives beat, guidance raised - Investing.com
Earnings call transcript: Elanco Animal Health Q1 2026 surpasses expectations with strong growth - Investing.com
elan-20260331 - SEC.gov
Elanco Animal Health Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Elanco Animal Health Reports Q1 2026 Results: Full Earnings Call Transcript - Benzinga
Elanco (NYSE: ELAN) grows Q1 2026 revenue 15% while profit declines - Stock Titan
Elanco Animal Health Incorporated : Investor Overview - marketscreener.com
Elanco (ELAN) shares climb after strong quarterly results and higher full-year outlook - Yahoo Finance
Elanco Animal Health Incorporated (ELAN) Beats Q1 Earnings and Revenue Estimates - Yahoo Finance
Elanco Animal Health Q1 Adjusted Earnings, Revenue Rises; Lifts 2026 Outlook - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Soars After Strong Q1 Beat, Raises Full-Year Outlook - ChartMill
(ELAN) Elanco Animal Health Expects 2026 Revenue Range $5.01B to $5.09B, vs. FactSet Est of $5.00B - marketscreener.com
Earnings Flash (ELAN) Elanco Animal Health Incorporated Posts Q1 Adjusted EPS $0.40 per Share, vs. FactSet Est of $0.35 - marketscreener.com
Elanco stock rises 6% on strong quarter, raised guidance By Investing.com - Investing.com Canada
Global Animal Euthanasia Market to Reach $3.26 Billion by 2036, - openPR.com
Elanco’s (NYSE:ELAN) Q1 CY2026 Sales Beat Estimates - TradingView
GUIDANCE: (ELAN) Elanco Animal Health Expects 2026 Adjusted EPS Range $1.03 to $1.09, Vs. FactSet Est of $1.03 - Moomoo
Elanco Animal Health Reports First Quarter 2026 Results - marketscreener.com
Press Release: Elanco Animal Health Reports First Quarter 2026 Results - Moomoo
Pet Parasite Prevention and Control Market Size Accelerating - openPR.com
Elanco (ELAN) officer awarded 65 deferred stock units under plan - Stock Titan
Elanco (NYSE: ELAN) CEO receives grant of deferred stock units as pay - Stock Titan
Elanco (ELAN) CFO receives new deferred stock unit award - Stock Titan
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
엘란코 주식 (ELAN) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Modi Rajeev A. | SEE REMARKS |
Dec 11 '25 |
Buy |
21.33 |
4,500 |
95,985 |
123,082 |
| VanHimbergen Robert M | EVP and CFO |
Dec 11 '25 |
Buy |
21.64 |
6,950 |
150,426 |
124,233 |
| Simmons Jeffrey N | PRESIDENT, CEO AND DIRECTOR |
Dec 11 '25 |
Buy |
21.75 |
22,000 |
478,496 |
167,000 |
1.49%
1.78%
자본화:
|
볼륨(24시간):